Medlior is a well-known and trusted industry leader.
Our team is dedicated to delivering high-quality research that provides a solid basis for informed decision-making.
Medlior’s Expert Angle offers the inside track on new studies, industry hot topics, and what you need to know in the fast-paced world of clinical research, all from the point of view of the Medlior team of experts. From the latest topics and trends to the foundations of health and medical research, Medlior explores topics relevant to clients and the world.
A systematic literature review
Osteoarthritis (OA) is a chronic joint disease that leads to a loss of articular cartilage, resulting in painful bone-on-bone contact. Females have a higher risk of developing OA compared to males, and obese individuals are three times more likely to develop OA. ...
As the COVID-19 virus spreads, world governments implement control strategies
This article is about an emerging and rapidly evolving public health crisis. Case and death counts change daily. If you’re interested in learning the very latest information please consult the World Health ...
Study on natural language processing and machine learning to develop oncology decision aid for multiple myeloma in Alberta
In Canada, approximately 2,900 people were diagnosed with multiple myeloma in 2017. Unique, targeted therapies are currently in development for multiple myeloma and will
This study will provide an integrated data source to inform follow-up clinical care pathways for cancer survivors in Alberta
The odds of long-term recovery from cancer have never been better. In the 1940s only 25% of Canadians survived a cancer diagnosis, compared with 60% ...
Obesity has traditionally been considered a result of lifestyle factors, including poor diet and physical inactivity, and thus, it has been considered a preventable condition. However, the Canadian Medical Association has recently declared obesity to be a chronic medical disease due to the associated negative health effects.9 While lifestyle modifications can prevent obesity in some, further pharmaceutical intervention is required to mitigate the growing obesity epidemic in Canada and reduce the national burden of disease.
In Canada, approximately 1,700 men and 1,200 women were diagnosed with multiple myeloma (MM) in 2017. While this only corresponds to 1.6% and 1.2% of new cancer cases each year, the approximate five-year net survival rate according to the Canadian Cancer Society (estimated for the years ...
Medlior continues to have our work featured in respected publications and this month we’re pleased to be published in Future Oncology. Our manuscript looks at First-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer: A systematic review and network meta-analysis. Read more here.